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Abstract
 
T cell clone 2C recognizes the alloantigen L
 
d
 
 and the positive selecting major histocompatibil-
ity complex (MHC), K
 
b
 
. To explore the molecular basis of T cell antigen receptor (TCR)
binding to different peptide/MHC (pMHC) complexes, we performed alanine scanning mu-
tagenesis of the 2C TCR. The TCR energy maps for QL9/L
 
d
 
 and SIYR/K
 
b
 
 were remarkably
similar, in that 16 of 41 V
 
a
 
 and V
 
b
 
 alanine mutants showed reduced binding to both ligands.
Several TCR residues varied in the magnitude of energy contributed to binding the two
ligands, indicating that there are also unique interactions. Residues in complementarity deter-
mining region 3
 
a
 
 showed the most notable differences in binding energetics among the ligands
QL9/L
 
d
 
, SIYR/K
 
b
 
, and the clonotypic antibody 1B2. Various lines of evidence suggest that
these differences relate to the mobility of this loop and point to the key role of conformational
dynamics in pMHC recognition.
Key words: T cell receptor • peptide–major histocompatibility complex • complementarity 
determining region • alloantigen • antigen recognition
 
Introduction
 
Structural analyses of TCR–peptide/MHC (pMHC)
 
1
 
 com-
plexes have suggested that TCRs interact with pMHC
ligands in a conserved, diagonal orientation (1–4). Wiley
and colleagues showed that residues at analogous positions
on two different TCRs (A6 and B7) contact the same
ligand, Tax/HLA-A2, in this conserved orientation (5). In
a more recent study, the structure of the A6 TCR was
solved in complex with three different peptide variants of
Tax, bound to HLA-A2 (6). The complexes appeared to
be very similar despite the fact that the peptides have dis-
tinct functional effects ranging from antagonist to strong
agonist. Thus, there was no obvious correlation between
structural features of the complexes and their biological ac-
tivity (e.g., agonist peptides did not exhibit significant in-
creases in the number of TCR contact residues compared
with antagonists).
It is perhaps not surprising that subtle changes in TCR
structure dramatically affect function, based on the very
narrow energetic windows of TCR–pMHC interactions
that underlie different T cell processes (i.e., positive versus
negative selection or agonism versus antagonism of mature
T cells) (7–9). For example, Gascoigne and colleagues
showed that the interaction of a TCR with an agonist and
antagonist pMHC exhibited only a threefold difference in
affinity (7). Earlier studies revealed that single amino acid
differences in a peptide could convert a peptide agonist
into an antagonist (10), and it is now widely recognized
that the same TCR can be stimulated by a diverse array of
peptides (11). The molecular basis for these observations
might be best understood in the context of TCR–pMHC
binding affinity measurements; the energy derived from a
single hydrogen bond could convert an agonist peptide
into an antagonist (9).
Although the three-dimensional structures of TCR–
pMHC complexes have provided tremendous insight into
how a TCR interacts with its ligand, it is not possible from
structures alone to understand what constitutes a produc-
tive, functional interaction. Discerning the properties of
TCR structures that are important in binding and function
will require additional approaches. In this regard, the work
of Wells has shown that the contact residues identified in
three-dimensional structures do not provide a picture of
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the important functional contacts (12). These can only be
discerned from a detailed mutagenic study (typically alanine
scans) of the protein interface and subsequent binding anal-
yses. Accordingly, it is important to understand which resi-
dues of the TCR actually impart the binding energy that is
responsible for functional processes and pMHC specificity.
One might expect these energy distributions to be similar
for the same TCR, binding only minor variants of a single
pMHC complex. For example, in the A6–Tax/HLA-A2
system, there are relatively minor differences in total energy
and these differences are presumably due to minor alter-
ations at the TCR–pMHC interface. On the other hand,
the recognition of self-MHC versus allo-MHC may be
considerably different, depending on the structural similar-
ity of the two MHC proteins.
The 2C T cell system (13) provides an opportunity to
examine these questions, as multiple pMHC ligands have
been identified and it has been thoroughly studied from
both structural and functional perspectives. In addition, the
2C TCR has the highest measured affinity for a pMHC
ligand, the alloantigen L
 
d
 
 bound to the peptide QL9 (QL-
SPFPFDL) (14). There are convenient K
 
b
 
-binding peptides
that act as either positive-selecting ligands (EQYKFYSV,
called dEV8; 15) or as strong agonists (SIYRYYGL, called
SIYR; 16). The structures of unliganded 2C TCR (1) and
the 2C TCR–dEV8/K
 
b
 
 (4) complex have been solved, and
we recently reported the energy map of the 2C TCR–
QL9/L
 
d
 
 interaction (17).
Alanine scanning mutagenesis of TCR–ligand interac-
tions are difficult because of the inherent low affinity of the
native TCR (so measurements for alanine mutants with re-
duced affinities are even more difficult). The 2C TCR–K
 
b
 
affinities are lower than the 2C TCR–QL9/L
 
d
 
 affinity (
 
K
 
D
 
 
 
5
 
2 
 
m
 
M for our soluble TCR; 18), making a comparison
of energy maps for self-MHC and allo-MHC difficult. In
our hands, the affinity of the 2C TCR–dEV8/K
 
b
 
 interac-
tion (
 
K
 
D
 
 
 
. 
 
100 
 
m
 
M) is at least 20-fold lower than the 2C
TCR–SIYR/K
 
b
 
 interaction (
 
K
 
D
 
 
 
5 
 
5 
 
m
 
M). In this report,
we show that a tetrameric pMHC (SIYRYYGL/K
 
b
 
) ligand
can be used in scans of these low-affinity interactions to
construct an energy map of the TCR surface. The ap-
proach takes advantage of the avidity of pMHC–streptavi-
din–horseradish peroxidase (SAv-HRP) tetramers to detect
binding multivalent arrays of TCR mutant proteins (19).
A comparison of the 2C TCR energy maps constructed
for the allogeneic L
 
d
 
 and the syngeneic K
 
b
 
 showed that
most of the same TCR residues were involved in each case.
In both cases, CDR1 and CDR2 of the V
 
a
 
 and V
 
b
 
 con-
tributed the majority of the energy. However, the V
 
b
 
 ap-
peared to contribute more energy, relative to V
 
a
 
, in the
SIYR/K
 
b
 
 interaction compared with the QL9/L
 
d
 
 interac-
tion. The HV4
 
b
 
 also appeared to exert a moderate effect
on binding the SIYR/K
 
b
 
 complex. Additional differences
in the magnitude of effects were also observed (31
 
a
 
Tyr,
55
 
a
 
Val, 28
 
b
 
Asn, and 70
 
b
 
Pro affected SIYR/K
 
b
 
 more than
QL9/L
 
d
 
, whereas 29
 
a
 
Thr, 49
 
a
 
Tyr, and 100
 
a
 
Phe affected
QL9/L
 
d
 
 more than SIYR/K
 
b
 
).
We also analyzed in greater detail the effects of muta-
 
tions in the CDR3
 
a
 
 loop of the 2C TCR, as this loop ex-
hibits the largest conformational difference (6 Å) in unli-
ganded TCR compared with liganded (dEV8/K
 
b
 
) TCR
(4). The results of temperature and mutational analyses sup-
port a model in which this loop of the TCR exists in mul-
tiple conformations. Stabilization of a conformational state(s)
can result in loss of binding to some ligands (QL9/L
 
d
 
 and
SIYR/K
 
b
 
) but strong binding to others (clonotypic anti-
body 1B2). A solution structure of the D10 TCR showed
that the CDR3 loops had considerable mobility (20), con-
sistent with recent thermodynamic studies of two different
TCR–pMHC interactions (21). Our findings suggest that
there are severe functional consequences to restricting this
mobility.
 
Materials and Methods
 
TCR Expression and Purification.
 
The 2C TCR was expressed
in 
 
Escherichia
 
 
 
coli
 
 as a single-chain (sc) protein as described previ-
ously (17, 22). Wild-type (wt) and single-site mutant scTCR
were refolded from inclusion bodies and purified over a denatur-
ing nickel affinity column. Monomeric scTCR was isolated by
HPLC G-200 size exclusion chromatography, and the purity of
the monomeric protein was assessed by SDS-PAGE.
 
mAbs.
 
F23.1 is a mouse IgG2a mAb specific for V
 
b
 
8.1,
V
 
b
 
8.2, and V
 
b
 
8.3 (23). 1B2 is a clonotypic mAb specific for the
V
 
a
 
 and V
 
b
 
 of the 2C TCR (24). Both antibodies were purified
from ascites by ammonium sulfate precipitation followed by
DEAE-cellulose chromatography. 1B2 binding to scTCR was
examined in a capture ELISA in which F23.1 mAb was immobi-
lized on Immulon plates (Dynatech Technologies). Wells were
washed with 0.5% BSA and 0.05% Tween 20 in PBS, and then
50 
 
m
 
l of wt or mutant scTCR was added at 10 
 
m
 
g/ml. After 30
min at 4
 
8
 
C, wells were washed and biotin-labeled 1B2 mAb was
added at various dilutions. Binding was detected with the addi-
tion of SAv-HRP and tetramethylbenzidine (TMB)-peroxidase
substrate (Kirkegaard & Perry).
 
Preparation of SIYR/K
 
b
 
 Tetramers.
 
Biotinylated SIYR/K
 
b
 
 was
prepared by labeling the refolded complex at a BirA recognition
sequence located at the COOH terminus of the MHC 
 
a
 
 chain
using the BirA enzyme (Avidity). Monomeric biotinylated
SIYR/K
 
b
 
 was isolated by HPLC G-200 size exclusion chroma-
tography. Tetramers were prepared by incubating the biotiny-
lated SIYR/K
 
b
 
 complexes with SAv-HRP at a calculated molar
ratio of 
 
.
 
200:1 biotinylated pMHC to SAv-HRP by addition of
biotinylated SIYR/K
 
b
 
 to SAv-HRP over 6 h at 4
 
8
 
C. In prelimi-
nary experiments, preparations of 4:1 and 200:1 SIYR/K
 
b
 
–SAv-
HRP were compared for their binding to wt TCR and two mu-
tants (
 
a
 
Y49A and 
 
a
 
F100A). Although the relative binding values
for each preparation were completely consistent among the three
different TCR proteins, the 200:1 preparation had a considerably
higher signal and accordingly was used for analyses of all mutants.
Two different commercial preparations of SAv-HRP (Kirkegaard
& Perry) were also examined at the 200:1 ratio and were found to
have significant differences in their activity. It is possible that
these differences relate to the SAv-HRP heterogenity derived
from chemical coupling of HRP (e.g., some SAv molecules are
likely to be unlabeled with HRP and might compete with labeled
molecules, and some SAv molecules are likely to be labeled at the
biotin binding sites and therefore would exhibit lower valencies).
 
Peptide–MHC Binding Assays.
 
Direct adsorption of scTCR to 
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wells did not yield detectable binding by either SIYR/K
 
b
 
 tetra-
mers or 1B2, probably because the scTCR was immobilized in an
orientation that was not accessible to these ligands. Because the
F23.1 epitope does not overlap with the binding sites for either
SIYR/K
 
b
 
 or 1B2, we used adsorbed F23.1 mAb as a way to ori-
ent the scTCR in a uniform multivalent layer. 50 
 
m
 
l of F23.1
mAb (10 
 
m
 
g/ml) was adsorbed to Immulon wells, which were
then washed, and scTCR preparations were added. In initial ex-
periments, the concentration of scTCR (wt or mutant) was var-
ied to explore the sensitivity of the assay. All subsequent experi-
ments that involved titrations of SIYR/K
 
b
 
 tetramers involved the
use of scTCR at a saturating concentration of 10 
 
m
 
g/ml. After in-
cubation with scTCR, wells were washed and then incubated
with 50 
 
m
 
l of a dilution of SIYR/K
 
b
 
 tetramer or 1B2 for 30 min.
After washing, binding was detected by addition of TMB-perox-
idase substrate. Except where noted, binding assays of scTCR
mutants were performed at 4
 
8
 
C because this is the temperature at
which the alanine scan of the 2C–QL9/L
 
d
 
 interaction was per-
formed (17). The relative reactivities of wt TCR and mutants
 
a
 
Y49A and 
 
a
 
F100A incubated with SIYR/K
 
b
 
 at two different
temperatures (4
 
8
 
C and 25
 
8
 
C) and for various times (30, 60, and
120 min) were completely consistent.
The wt scTCR and several mutants (
 
b
 
T55A, 
 
b
 
Q72A,
 
a
 
Y49A, and 
 
a
 
F100A) were also examined by a similar F23.1 cap-
ture ELISA, titrated at various concentrations of QL9/L
 
d
 
 Ig
dimer (25, 26). Bound QL9/L
 
d
 
 Ig dimer was detected with
HRP-labeled goat anti–mouse 
 
l
 
 (Southern Biotechnology Asso-
ciates).
 
Analysis of Binding Data.
 
Binding data from the pMHC tet-
ramer ELISAs were initially analyzed by three different parame-
ters to determine the most reliable measure of activity: maximum
absorbance achieved at the highest concentration of ligand (tet-
ramer or 1B2), concentration of ligand at half-maximal binding,
and slopes of regression lines from double reciprocal plots
(absorbance
 
2
 
1
 
 versus tetramer concentration
 
2
 
1
 
). Although all
three parameters yielded the same relative activities for the wt
scTCR and the array of alanine mutants, the slopes from double
reciprocal plots were found to be least subject to variability from
assay to assay. Thus, these slopes were used to establish the rela-
tive reactivities, calculated as the logarithm of (the slope of mu-
tant scTCR divided by the slope of wt scTCR). Those mutants
that did not exhibit detectable binding to the tetramer complex
were considered to have 
 
.
 
15-fold reduced binding, which was
the approximate working range of relative reactivities. This limit
was also approximately that found with a different pMHC bind-
ing assay in the alanine scan of the 2C–QL9/L
 
d
 
 interaction (17).
Structural Analysis. The crystal structure of the 2C–dEV8/Kb
complex (4) was used as a guide to interpret the alanine scan of
the 2C–SIYR/Kb interaction. The QUANTA software package
(Molecular Simulations) was used on a Silicon Graphics O2
workstation. Peptide versus MHC reactivity assignments were
made based on the structure of the 2C–dEV8/Kb complex.
QUANTA was also used to display the conformations of the
CDR3a region in its liganded (2C–dEV8/Kb) and unliganded
(2C TCR) forms.
Results and Discussion
Binding of 2C TCR to SIYR/Kb Tetramers. Previous
work with soluble versions of the 2C TCR showed that an
scTCR with an NH2-terminal thioredoxin fusion increased
its solubility such that it could be used to monitor binding
to the QL9/Ld alloantigen (22). Thus, a panel of alanine
mutants of the 2C scTCR were used to determine, in a
quantitative competition assay with 125I-labeled anti-Ld Fab
fragments, the binding energy associated with each mutant
protein (17). Similar assays to examine the binding of the
scTCR to the agonist peptide SIYR bound to the positive
selecting class I molecule Kb were unsuccessful (data not
shown), most likely because of the lower affinity of the 2C
TCR–SIYR/Kb interaction. Recent studies have shown
that cell surface binding of soluble pMHC to the TCR can
be detected by increasing the avidity of the interaction
through the use of pMHC tetramers (19). This suggested to
us that a similar approach might allow the detection of re-
combinant TCR, if the TCR were arrayed in a multivalent
layer in an ELISA format.
Soluble, refolded scTCRs were added to wells that con-
tained the anti-Vb antibody F23.1 (23). F23.1 recognizes a
framework region of the Vb8 domain, and its binding site
does not overlap with that of either pMHC or the clono-
typic antibody 1B2 (17). After addition of scTCR, wells
were washed and incubated with a tetramer of biotinylated
SIYR/Kb bound to SAv-HRP, followed by substrate. Each
scTCR was assayed at various concentrations of the tet-
ramer to construct titration curves of the wt 2C scTCR
and the panel of alanine mutants (Fig. 1). No binding was
detected in the absence of the TCR or the biotinylated Kb,
and the binding of the tetrameric SIYR/Kb could be com-
pletely blocked with the anticlonotypic antibody 1B2,
which recognizes an epitope that is very similar to the
pMHC binding site (data not shown). Because this binding
assay involves multivalent interactions, it was not possible
Figure 1. SIYR/Kb tetramer complexes binding to wt 2C scTCR
and to representative scTCR alanine mutants. SIYR/Kb tetramer bind-
ing was examined in a capture ELISA. scTCR was added to immobi-
lized F23.1 mAb, and then various concentrations of the SIYR/Kb–
SAv-HRP tetramer were added, followed by incubation with substrate.
Binding was completely inhibited by unlabeled clonotypic 1B2 antibody
(data not shown), indicating that the pMHC binds at the expected TCR
binding site.1358 Mapping the Energy of TCR Antigen Recognition
to calculate the intrinsic binding constant for each scTCR
mutant. Various strategies were explored to determine the
most appropriate parameter for comparing wt scTCR
binding to the mutant scTCR (see Materials and Meth-
ods). Ultimately, the slope of double reciprocal plots
(absorbance21 versus concentration21) were found to be
reliable measures of binding, and calculations of binding
contribution were made relative to wt scTCR. The range
of values (log reactivity relative to wt scTCR) for the en-
tire panel of 46 mutants was found to be very similar to the
actual range of energies (DDG) calculated in the QL9/Ld
binding study (see below and reference 17).
Effect of Alanine Mutations on SIYR/Kb Binding. Tet-
ramer (SIYR/Kb–SAv-HRP) titrations of the 46 different
single-site mutants within the CDR and HV loops of the
2C TCR were performed (Fig. 2). The majority of resi-
dues that influenced binding most significantly were in
CDR1 and CDR2 of the Va and Vb. This finding is con-
sistent with the distribution of contact residues in the struc-
ture of the 2C TCR–dEV8/Kb complex (4). Although
none of the HV4a residues appeared to affect SIYR/Kb
recognition, several HV4b region residues (70bPro,
72bGln, and 76bSer) had moderate effects. These results
could be due to direct interactions with pMHC or through
indirect effects on other CDR loops. For instance, the
HV4b is in close proximity to CDR1b and CDR2b,
which have significant effects on SIYR/Kb binding and
72bGln hydrogen bonds with the main-chain oxygen of
28bAsn. On the other hand, the differences between the
effects of HV4b mutations on SIYR/Kb compared with
QL9/Ld binding (see below) may suggest additional direct
interactions with SIYR/Kb.
The following residues contact either peptide dEV8 or
Kb in the structure and, based on a reduction in binding of
the alanine mutant (more than threefold compared with
wt), contribute significant energy to binding: 26aTyr (Kb),
31aTyr (peptide/Kb), 50aTyr (Kb), 28bAsn (Kb), 31bAsn
(peptide), 50bTyr (Kb), and 97bGly (peptide/Kb). As in
other alanine scans, some residues shown to be in contact
in the crystal structure do not appear to contribute energy
to the interaction. The following residues contact either
dEV8 or Kb in the structure but did not contribute signifi-
cant energy to binding: 27aSer (Kb), 51aSer (Kb), 93aSer
(peptide), 100aPhe (peptide/Kb), 26bThr (Kb), 55bThr
(Kb), and 56bGlu (Kb). Finally, some residues within the
CDR and HV loops do not contact either dEV8 or Kb in
the structure but the alanine mutants exhibited a significant
reduction in binding: 30aPro, 49aTyr, 55aVal, 104aLeu,
27bAsn, 30bAsn, 48bTyr, 70bPro, and 106bLeu. It has
been thought that mutations such as these could act
through destabilization of adjacent residues or loops, as
most of them are in close proximity to other residues.
However, evidence suggests that some mutations may sta-
bilize the TCR, which could also lead to reduced binding
(e.g., 104aLeu; see CDR3a below). In these latter cases,
there may be a reduction in entropy associated with de-
creased conformational mobility, and this mobility may be
necessary for binding of some ligands.
There has been particular interest in the role of Va resi-
dues 27 and 51 in pMHC binding (27). These residues
Figure 2. Binding of SIYR/Kb to single-site 2C scTCR mutants. The relative reactivity of SIYR/Kb binding to scTCR mutants was calculated from
double reciprocal plots (absorbance21 versus tetramer concentration21) of the binding data shown in Fig. 1, as described in Materials and Methods. Bars
that extend above the zero line indicate mutants that exhibit decreased binding to SIYR/Kb compared with wt scTCR. Bars that extend below the zero
line indicate mutants that show improvement in binding to SIYR/Kb. Error bars indicate the SD calculated from two or more experiments. Mutant
scTCR indicated by an asterisk (*) exhibited significantly reduced but detectable binding in one assay (actual values shown) but no detectable binding in
other assays. Mutant aY31A did not show binding to SIYR/Kb in any assay and was considered to be below the limit of detection in this assay (approxi-
mated in the value shown).1359 Lee et al.
have been implicated in the CD4/CD8 skewing associated
with the Va3 system (28), and they are in direct contact
with Kb residues (Glu 58 and Arg 62 of Kb contacting
TCR 27aSer, and Ala 152, Gly 162, and Glu 166 of Kb
contacting TCR 51aSer). As recently observed for the
QL9/Ld interaction (18), alanine mutations at TCR posi-
tions Sera27 and Sera51 had little effect on SIYR/Kb
binding (Fig. 3). It is possible that there is a compensatory
involvement of water molecule(s) in the alanine mutants or
that these residues impact T cell function through effects
on kinetics rather than equilibrium binding, as we have re-
cently suggested (18). Because polymorphisms at these po-
sitions (Phea27 and Proa51) have been shown to skew
Va31 T cells to the CD8 phenotype in an H-2b back-
ground, we also examined the effects of these mutations,
individually and together, on SIYR/Kb binding. The orig-
inal expectation was that the Phea27 and Proa51 residues
may act by increasing the affinity of the TCR for class I,
thereby skewing selection of the T cell into the CD8 com-
partment. However, as observed for QL9/Ld binding, these
mutations had negative effects on binding of the 2C TCR
to SIYR/Kb (Fig. 3). This result is consistent with the
quantitative instruction model of lineage commitment (29,
30), which predicts that higher affinity TCR interactions
(27aSer and 51aSer) skew cells toward a CD4 lineage or
deletion, whereas moderate affinity TCR interactions skew
cells toward a CD8 lineage (27aPhe and 51aPro). It is also
possible that at least some T cells do not require the TCR–
class II interaction at all to complete development along the
CD4 lineage (31).
Comparison of TCR Energy Maps for Binding to SIYR/Kb
and QL9/Ld. An alanine scan does not address the role of
interactions between the peptide backbone of the TCR
and pMHC. Although these interactions contribute energy
to the overall interaction and may in some cases be pMHC
specific, they cannot be responsible for the diversity and
specificity associated with pMHC recognition. The fact
that the 2C TCR recognizes two very different pMHC
complexes allows us to examine if the TCR residues re-
sponsible for these specificities differ. Binding data for the
2C TCR mutants with self-MHC (this report) and allo-
MHC ligands (17) were used to construct TCR energy
maps for both interactions. Fig. 4 compares the hot spots of
binding associated with 2C TCR binding to SIYR/Kb and
QL9/Ld. Both interactions involve two hot spots that lie
diagonally over the MHC helices. Overall, the same re-
gions of the TCR at the interface are involved in binding
each ligand, with subtle but significant changes in the role
of individual residues. These appear to be largely differ-
ences in the magnitude of the contribution rather than the
presence or absence of an effect. The most significant dif-
ferences were residues 31aTyr, 55aVal, 28bAsn, 70bPro,
and 72bGln, which affected SIYR/Kb more than QL9/Ld,
and 29aThr, 49aTyr, and 100aPhe, which affected QL9/
Ld more than SIYR/Kb. Several mutants were examined
with QL9/Ld Ig dimer to confirm that these differences
were not a consequence of reduced mobility or increased
valency with the SIYR/Kb–SAv-HRP approach. The re-
sults with the QL9/Ld Ig dimer were completely identical
to those obtained with monomeric QL9/Ld in the previ-
ously reported alanine scan (i.e., binding order: bT55A .
wt . bQ72A . aF100A . aY49A; data not shown and
reference 17).
Thus, the overall TCR energy distribution appears to
have been shifted slightly from the peptide NH2 end in
QL9/Ld binding to the peptide COOH end in SIYR/Kb.
A recent study showed that two mAbs specific for the
OVA-8/Kb complex mapped to the peptide COOH end
of the complex (32). One interpretation of these results
is that this region of the Kb molecule is more accessible
than Ld.
Table I summarizes the approximate relative binding en-
ergies contributed by each of the 2C TCR loops. As sug-
gested from the representation shown in Fig. 4, there is re-
markable similarity in the role of TCR regions for binding
both the self- and the allo-MHC ligands. These similarities
may derive from the overall surface topology of the pMHC
complex (i.e., only particular regions are exposed and thus
potential contact areas). Furthermore, selection on a class I
MHC during thymic development (Kb in this case) predis-
poses TCR residues to be involved in structurally related
allo-MHC molecules (Ld in this case). However, it is also
of interest that there appears to be an increase in binding
energy associated with the Vb chain and SIYR/Kb recog-
nition compared with QL9/Ld recognition. The increased
Vb involvement is due largely to the HV4 loop, suggesting
that this may play a greater role in SIYR/Kb contact than
in QL9/Ld contact. Speir et al. have suggested that the
HV4 region (69bArg in particular) could contribute elec-
trostatic forces to the interaction with ligand, but their
model suggested that this effect would be more pro-
Figure 3. Binding of SIYR/Kb to scTCR mutants known to be in-
volved in CD4/CD8 repertoire skewing. The reactivity of alanine mu-
tants (S27A and S51A) as well as CD8 skewing mutants (S27F, S51P, and
double mutant S27F/S51P) was calculated relative to wt scTCR as de-
scribed in the legend to Fig. 2 and in Materials and Methods. Error bars
indicate the SD calculated from two or more assays.1360 Mapping the Energy of TCR Antigen Recognition
nounced in the 2C TCR–QL9/Ld interaction (33). A
structure of the 2C TCR–QL9/Ld complex would be nec-
essary to determine if the 2C Vb is positioned differently
than in the SIYR/Kb complex. There is precedence for re-
duced involvement of a Vb chain in the A6–Tax/HLA-A2
structure (2).
It is interesting that the distribution of energetic contacts
displays a twofold symmetry of binding across the diagonal
axis. In fact, residues at the equivalent positions in the Va
and Vb (positions 31 and 50) appear to be the key focal
points of binding, perhaps analogous to homodimers that
form in other receptor–ligand interactions. Although this
dimeric configuration cannot be generally true of all TCRs
(based on the observation that at least the A6–Tax/HLA-A2
interaction does not involve Vb CDR1 and CDR2 [2]), it is
possible that different Va and Vb have evolved residues at
these positions to facilitate binding along this twofold axis of
symmetry. This could account in part for earlier observations
that some Vb regions were predisposed to interact with par-
ticular MHC alleles (34) and that there appears to be prefer-
ential expression of specific VaVb pairs (35, 36).
The distribution of energy among TCR side chains that
contact peptide or MHC is approximately the same in the
TCR–SIYR/Kb and TCR–QL9/Ld interactions. Thus,
about one third of the energy is directed at the peptide and
two thirds of the energy is directed at the helices. Such bias
towards the MHC helices in the interaction with syngeneic
MHC could account for findings that unrelated peptides
can activate mature T cells (37) and that many peptides can
participate in the positive selection process (38). As dis-
cussed previously, interactions with MHC helices selected
during thymic development can provide a basal affinity,
whereas interactions with peptide provide sufficient in-
creases in energy to drive T cell activity and confer peptide
specificity (9).
Table I. Percent Contributions of CD4 and HV4 Regions to 
Binding SIYR/Kb and QL9/Ld
SIYR/Kb QL9/Ld
CDR1a 26 33
CDR2a 17 17
HV4a2 32
CDR3a 71 0
CDR1b 18 15
CDR2b 15 14
HD4b 11 0
CDR3b 99
Va 47 62
Vb 53 38
The percentage of total energy distributed among the different CDR
and HV regions was calculated from log reactivity values (SIYR/Kb) or
free energy (DDG) values (QL9/Ld from reference 17). To standardize
the comparison, maximum reductions in binding for each assay were set
at 15-fold (because of the slightly different sensitivities of the two assay
formats). Residues that were not tested for QL9/Ld binding (see text)
were not included in the SIYR/Kb calculations.
Figure 4. Energy maps of the 2C TCR binding sites for QL9/Ld and SIYR/Kb. CDR and HV4 region residues are highlighted based on their influ-
ence on peptide–MHC binding, when mutated to alanine. Red indicates those residues with the greatest effect on binding; pink are those residues with
an intermediate effect; yellow are those residues with a negligible effect; and green are those residues that exhibit improved binding. The 2C–QL9/Ld
epitope, previously determined by Manning et al. (reference 17), is shown with the QL9/Ld MHC helices and peptide superimposed. The 2C–SIYR/Kb
epitope, determined in this study, is shown with the dEV8/Kb MHC helices and peptide superimposed. The refined crystal structure of the 2C–dEV8/Kb
complex was used to establish the orientation of pMHC binding to TCR. Several alanine mutants (aV56A, bN30A, bG51A, bA52W, and bG53A)
were not tested for QL9/Ld binding but are included in the dEV8/Kb map.1361 Lee et al.
TCR Energy Map for Binding to SIYR/Kb and Epitope Map
of Key Kb Residues. A study by Nathenson and colleagues
several years ago used a panel of Kb mutants and various
Kb-restricted and alloreactive T cell clones to identify the
regions of the Kb helices that are involved in T cell recog-
nition (39). The results suggested that two regions at oppo-
site positions on the two helices contain hot spots for TCR
recognition, leading to the first proposal that the TCR may
orient diagonally on the pMHC. Superimposing the Kb he-
lices, with the eight key residues highlighted, on the 2C
TCR energy map shows that these Kb residues reside very
near the TCR hot spots identified in our alanine scan (Fig.
5). Six of the Kb residues were located within 3.8–10.7 Å of
a TCR residue determined to contribute significant energy
to the interaction. The two most distal residues (Leu82 and
Asn174) were located 12 and 15 Å from the nearest TCR
residue found to be important in binding. Interestingly, all
8 of these Kb residues are identical in the Ld molecule, even
though Kb and Ld differ by a total of 41 residues (14 in a1,
18 in a2, and 9 in a3). Thus, we predict that in alloreactiv-
ity the majority of the TCR binding energy is focused on
those residues that are shared between the self-MHC re-
stricting element and the allo-MHC, and that the addi-
tional energy derived from minor differences in MHC and/
or peptide are sufficient to elicit agonist activity.
As discussed above, some of the interactions involving
these Kb residues involve TCR backbone contacts that
would not be assessed in an alanine scan. As 30–90% of the
59 T cell clones in the Sun et al. study were affected by the
set of Kb mutations highlighted in Fig. 5 (39), it is reason-
able to predict that other TCRs will exhibit energy distri-
butions similar to the 2C TCR. Conversely, do other class I
MHC alleles have similar hot spots that are recognized by
different TCRs? The observation that the 2C TCR energy
map is nearly identical whether the MHC ligand is Kb or Ld
supports this possibility. Additional evidence has come from
several observations: (a) limited mutagenesis of other class I
molecules, including a recent study of Ld (40), is consistent
with the general contact areas shown in Fig. 5; (b) many al-
loreactive T cell clones raised in Kb-negative mice (and
therefore with quite different positive-selecting class I mol-
ecules) still recognized this same pattern on the Kb molecule
(39); and (c) the crystal structures of TCR–pMHC com-
plexes have so far uniformly illustrated the conserved topol-
ogy of these interactions. The supposition that TCRs have
evolved to recognize MHC (41) suggests that the critical
residues found within the hot spot regions of the TCR rep-
resent the target of such longer term selection.
Effect of CDR3a Mutations: Evidence of Multiple Conforma-
tional States of the TCR. The CDR3 loop of the 2C TCR
(SGFASAL) exhibits the largest difference in structure when
comparing the unliganded 2C TCR and the liganded
TCR (TCR–dEV8/Kb) (4). In the liganded structure the
apical residue, Phe100, has moved 6 Å such that it is
aligned along the axis of the Kb a1 helices (Fig. 6). This
movement appears to be necessary to allow the TCR to
dock onto the pMHC without interference from the pro-
truding side chain of Phe100. Comparison of the effects of
the CDR3a alanine mutants on the three ligands (Fig. 7 A)
revealed significant differences that are in part related to the
conformational flexibility of this loop. The F100A mutant
Figure 5. Location of Kb residues known to affect activity of Kb-
restricted or alloreactive T cell clones. H-2Kb residues that were previously
identified as important in the activity of a panel of 59 T cell clones (refer-
ence 39) are superimposed on the 2C–SIYR/Kb epitope. Single-site mu-
tations at the eight highlighted Kb residues (blue circles) were shown to af-
fect T cell activity of 30–90% of the T cell clones tested (reference 39). Six
of the Kb residues are in close proximity to TCR residues that influenced
binding of peptide–MHC, whereas two residues (Leu82 and Asn174) are
.10 Å from the nearest TCR residue (pink or red) that had a significant
effect on SIYR/Kb binding. All eight residues are identical in Ld.
Figure 6. 2C CDR3a loop in liganded and unliganded conformations.
CDR3a in its unliganded state (blue strand) is superimposed on the struc-
ture of CDR3a in its bound state with dEV8/Kb pMHC (red strand)
generated from crystal structures of the unliganded 2C TCR (reference 1)
and the 2C–dEV8/Kb complex (reference 4).1362 Mapping the Energy of TCR Antigen Recognition
of the 2C TCR showed the greatest variation in binding
effects, of all of the TCR residues, to the three ligands 1B2,
QL9/Ld, and SIYR/Kb. Phe100 was the most important
residue for binding 1B2, it had a moderate contribution to
QL9/Ld binding, and it had, if anything, a negative effect
on binding to SIYR/Kb. Based on the structures of this
TCR, these results are consistent with the possibility that
there is an entropic penalty in binding the Kb ligand. We
propose that in the TCR–1B2 complex, Phe100 is a con-
tact residue that is associated directly with 1B2 CDRs, per-
haps in a conformation that is close to that of the unli-
ganded TCR (accordingly, there would not be a loss of
binding energy due to entropic effects). The intermediate
effect of binding to the QL9/Ld ligand leads to the predic-
tion that the Phe100 may be in yet a different conforma-
tion in the QL9/Ld complex.
L104A of CDR3a was the only alanine mutant tested that
had a significant effect on binding of the pMHC complexes
but no effect on the binding of 1B2. As shown in Fig. 6,
Leu104 is not positioned near the binding site but is buried
and in proximity to residues from other CDRs. Thus, the
considerable reduction in binding of pMHC is likely to be
due to effects of the alanine substitution on the conformation
of this region of the receptor. How might this alanine muta-
tion exert such effects? Evidence suggests that this mutation
may act by altering the conformational states of the CDR3a
loop. We have recently shown that a proline mutation at this
position (L104P) increases the thermal stability of the TCR,
yet this mutant has the same binding properties as the L104A
mutant (i.e., it binds 1B2 but does not bind QL9/Ld) (42,
43). This finding is consistent with the possibility that the
CDR3a loop is stabilized in the L104 mutants in the “unli-
ganded” conformation, capable of binding 1B2 but not
pMHC. This proposed mechanism is in accord with the ob-
servation that CDR3a exhibits the largest conformation dif-
ference in bound and unbound states.
Recent studies showed that temperature had unexpected
effects on TCR–pMHC binding, suggesting that there is
flexibility in the TCR (21) or perhaps even conformational
changes that lead to TCR dimerization (44). We have also
found that some 2C TCR–pMHC interactions may in-
crease their binding affinities with an increase in tempera-
ture, consistent with a large entropic contribution that
might be associated with conformational flexibility (45). To
explore this further, we examined the effects of tempera-
ture on binding by alanine mutants of the two residues in
CDR3a (Ser93 and Ser102) that had minimal effect on
binding to either 1B2 or pMHC (Fig. 7 A). Each of these
mutants was titrated at 48C, 258C, and 378C with the
ligands 1B2 and SIYR/Kb, and binding activity was calcu-
lated relative to the wt TCR (Fig. 7 B). The binding of
1B2 and SIYR/Kb showed completely opposite effects for
both mutants: an increase in temperature led to reduced
binding for 1B2, whereas an increase in temperature led to
increased binding for SIYR/Kb. Although it is not possible
to calculate enthalpy values directly from this assay, the ef-
fects are consistent with an unfavorable entropic contribu-
tion associated with the presence of serine residues at these
positions. Accordingly, alanine substitutions at these posi-
tions could affect the flexibility of the loop (albeit to a lesser
degree than the Leu104 mutations). In this model, binding
of SIYR/Kb benefits from the increased CDR3a move-
ment at higher temperatures because this ligand requires
that the TCR bind in a conformation that represents a low
frequency state of the TCR. In contrast, 1B2 binding is re-
duced at higher temperatures because this ligand interacts
with the predominant, unliganded conformation of the
TCR, and at higher temperatures this state is less frequent.
The binding of the anticlonotypic antibody 1B2 to the
predominant TCR conformation might be expected from
the manner in which this antibody was generated. 1B2 is a
high affinity antibody that was isolated from a mouse that
Figure 7. Effect of CDR3a
mutations on binding to QL9/
Ld, SIYR/Kb, and mAb 1B2.
(A) Effect of 2C TCR CDR3a
mutations on binding the three
different ligands at 48C. Reac-
tivity of CDR3a alanine mu-
tants for SIYR/Kb tetramer
complexes and mAb 1B2 was as-
sessed in ELISAs as described in
Materials and Methods. QL9/Ld
reactivity was determined in a
competition assay with 125I-labeled
anti-Ld Fab fragments as reported
previously (reference 17). (B) Ef-
fect of temperature on mAb 1B2
and SIYR/Kb binding to Va
mutants S93 and S102. Binding
of scTCR alanine mutants S93
and S102 was tested at 48C,
258C, and 378C. Error bars indi-
cate the reactivity values calcu-
lated from two independent
ELISA titrations.1363 Lee et al.
had been immunized six times with native clone 2C T cells
(13). Clonotypic antibodies are notoriously difficult to pro-
duce and thus those that are identified are likely to recog-
nize the TCR conformation that predominates in the im-
munogen preparation. In contrast, there appears to be less
selective pressure for high affinity interactions of the TCR
with pMHC, and in fact such interactions would normally
lead to T cell deletion during thymic development.
Although the crystal structures of the 2C TCR represent
two possible conformations of the TCR, there are very
likely dynamic and heterogeneous forms in the unliganded,
solution state. In fact, a recent solution structure of the D10
TCR has shown that CDR3 loops exhibited the greatest
mobility among the regions of the scTCR that were ana-
lyzed (20). As they suggest, hydrogen bonding (as seen for
several of the serine residues in the 2C TCR crystal struc-
ture) may restrict mobility and thereby affect the entropy of
the interactions. Such effects may in part account for our
observations that serine residues of the 2C TCR frequently
exhibit no effect when changed to alanine or even display
increases in affinity (18). The observations that on-rates of
TCR–pMHC interactions are typically slower than the on-
rates of antibody–antigen interactions (8, 46) are consistent
with the notion that most TCRs are in dynamic equilib-
rium among various conformations and that the lower fre-
quency forms bind to the pMHC ligands. Similar observa-
tions have been made for antibodies, especially those of
low affinity that have been isolated after a single immuniza-
tion (47). A germline-encoded antibody showed different
conformations in the free and bound states, whereas the
unbound form of a high affinity variant adopted a confor-
mation similar to that of the germline antibody in the
bound state (48). A recent study provided both kinetic and
thermodynamic evidence that TCR–pMHC binding ex-
hibited an unfavorable entropic component, suggesting that
a particular TCR conformation is stabilized in the bound
state (21). Consequently, a proposed induced-fit mecha-
nism suggests that TCRs scan multiple pMHC complexes
until a particular structural interaction gives rise to folding
transitions that allow TCR binding (49). The presence of
many conformations within a single TCR could provide
the T cell an opportunity to recognize many different pep-
tide–MHC molecules (11, 50), either because it is advanta-
geous to do so during positive selection or because this in-
creases the functional diversity already generated in the
TCR repertoire through genetic mechanisms.
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